UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 79 filers reported holding UTAH MED PRODS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $178,583 | +110.9% | 2,673 | +124.4% | 0.00% | – |
Q1 2024 | $84,692 | +8.6% | 1,191 | +28.6% | 0.00% | – |
Q4 2023 | $77,988 | -53.1% | 926 | -52.1% | 0.00% | – |
Q3 2023 | $166,324 | -7.7% | 1,934 | 0.0% | 0.00% | – |
Q2 2023 | $180,249 | +105.0% | 1,934 | +108.4% | 0.00% | – |
Q1 2023 | $87,947 | -5.7% | 928 | 0.0% | 0.00% | – |
Q4 2022 | $93,292 | +7.2% | 928 | -9.3% | 0.00% | – |
Q3 2022 | $87,000 | -2.2% | 1,023 | -1.3% | 0.00% | – |
Q2 2022 | $89,000 | -8.2% | 1,036 | -4.0% | 0.00% | – |
Q1 2022 | $97,000 | -5.8% | 1,079 | +4.8% | 0.00% | – |
Q4 2021 | $103,000 | +6.2% | 1,030 | -1.9% | 0.00% | – |
Q3 2021 | $97,000 | -3.0% | 1,050 | -11.0% | 0.00% | – |
Q2 2021 | $100,000 | -2.0% | 1,180 | 0.0% | 0.00% | – |
Q1 2021 | $102,000 | -68.1% | 1,180 | -65.2% | 0.00% | – |
Q1 2020 | $320,000 | +75.8% | 3,392 | +101.4% | 0.00% | – |
Q4 2019 | $182,000 | +40.0% | 1,684 | +23.7% | 0.00% | – |
Q3 2019 | $130,000 | – | 1,361 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nine Ten Partners LP | 271,139 | $16,282,000 | 5.30% |
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC | 188,732 | $11,333,000 | 2.93% |
Opus Capital Group, LLC | 36,877 | $2,214,000 | 0.32% |
Clean Yield Group | 8,581 | $515,000 | 0.23% |
Ativo Capital Management LLC | 7,372 | $443,000 | 0.18% |
Ancora Advisors LLC | 22,009 | $1,322,000 | 0.16% |
Penobscot Investment Management Company, Inc. | 6,000 | $360,000 | 0.11% |
Wallace Capital Management Inc. | 9,010 | $541,000 | 0.10% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,300 | $2,180,000 | 0.05% |
CONNORS INVESTOR SERVICES INC | 3,591 | $216,000 | 0.05% |